weakness_Piga<tm1Bsl>/Piga<+>,Tg(Fes-cre)31Bsl/0

http://metadb.riken.jp/0000746I129S1SvC57BL6CBACaPigatm1BslPigaTgFescre31Bsl0Pigatm1BslTgFescre31BslPiga

weakness_Piga<tm1Bsl>/Piga<+>,Tg(Fes-cre)31Bsl/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• phosphatidylinositol glycan anchor biosynthesis, class A
  http://metadb.riken.jp/db/mgi_rdf/MGI:99461
• transgene insertion 31, Monica Bessler
  http://metadb.riken.jp/db/mgi_rdf/MGI:2450256

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Piga<tm1Bsl>/Piga<+>,Tg(Fes-cre)31Bsl/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Piga<tm1Bsl>|Tg(Fes-cre)31Bsl|Piga<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S1/Sv * C57BL/6 * CBA/Ca

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• weakness
  http://purl.obolibrary.org/obo/MP_0000746

文献

http://purl.org/net/cito/citesAsAuthority

• P. Keller, et.al., FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow., The Journal of experimental medicine, 2001, 194
  http://rdf.ncbi.nlm.nih.gov/pubmed/11535627